Zoliget 15/2mg Tablet – Once-Daily Triple-Mechanism Power for Difficult Type-2 Diabetes
Zoliget 15/2mg Tablet – Once-Daily Triple-Mechanism Power for Difficult Type-2 Diabetes
Zoliget 15/2mg Tablet – Once-Daily Triple-Mechanism Power for Difficult Type-2 Diabetes
Description
Zoliget 15/2mg Tablet – Pioglitazone 15mg + Glimepiride 2mg Insulin-Sensitiser + Secretagogue Combo
Zoliget 15/2mg is a smart fixed-dose duo that pairs the proven insulin-sensitising action of Pioglitazone 15mg with the reliable pancreatic boost of Glimepiride 2mg in one morning tablet. This combination directly improves insulin resistance (liver and musclewhile gently stimulating remaining beta-cell function, delivering an average HbA1c fall of 1.8–2.6% in patients with high fasting glucose and long-duration diabetes. Perfect when metformin causes GI intolerance or is contraindicated, and for those needing stronger fasting sugar control without injecting insulin.


